Camptosar Genetic Test Launched By Genzyme
This article was originally published in The Pink Sheet Daily
Executive Summary
Invader assay identifies deficient UGT1A1*28 allele, which increases risk of neutropenia in colorectal cancer patients taking Camptosar.